{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:36:58Z","timestamp":1780497418721,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"37","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372604"],"award-info":[{"award-number":["82372604"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073104"],"award-info":[{"award-number":["82073104"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20441"],"award-info":[{"award-number":["U23A20441"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["21JC1404100"],"award-info":[{"award-number":["21JC1404100"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2025,9,29]]},"DOI":"10.1038\/s41388-025-03505-x","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:51:23Z","timestamp":1753159883000},"page":"3437-3448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["NSD2 promotes cell durotaxis and drives the transition from polycystic kidney disease to tubulocystic renal cell carcinoma through integrin\/FAK\/AKT signaling"],"prefix":"10.1038","volume":"44","author":[{"given":"Wenxin","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyu","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebiguli","family":"Aji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1989-4927","authenticated-orcid":false,"given":"Wei-Qiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2342-3658","authenticated-orcid":false,"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"3505_CR1","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41379-018-0185-5","volume":"32","author":"J Sarungbam","year":"2019","unstructured":"Sarungbam J, Mehra R, Tomlins SA, Smith SC, Jayakumaran G, Al-Ahmadie H, et al. Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile. Modern Pathol. 2019;32:701\u20139.","journal-title":"Modern Pathol"},{"key":"3505_CR2","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/PAS.0b013e3181872d3f","volume":"33","author":"MB Amin","year":"2009","unstructured":"Amin MB, MacLennan GT, Gupta R, Grignon D, Paraf F, Vieillefond A, et al. Tubulocystic Carcinoma of the Kidney: Clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma. American J Surg Pathol. 2009;33:384.","journal-title":"American J Surg Pathol"},{"key":"3505_CR3","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1158\/0008-5472.CAN-20-3960","volume":"81","author":"H Rao","year":"2021","unstructured":"Rao H, Li X, Liu M, Liu J, Feng W, Tang H, et al. Multilevel Regulation of \u03b2-Catenin Activity by SETD2 Suppresses the Transition from Polycystic Kidney Disease to Clear Cell Renal Cell Carcinoma. Cancer Res. 2021;81:3554\u201367.","journal-title":"Cancer Res"},{"key":"3505_CR4","doi-asserted-by":"publisher","first-page":"205873842110029","DOI":"10.1177\/20587384211002966","volume":"35","author":"S Xing","year":"2021","unstructured":"Xing S, Liu A, Yang X, Chen L, Xu D. Tubulocystic renal cell carcinoma: Two-case report and literature review. Int J Immunopathol Pharm. 2021;35:205873842110029.","journal-title":"Int J Immunopathol Pharm"},{"key":"3505_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41585-018-0052-7","volume":"15","author":"AA De Cubas","year":"2018","unstructured":"De Cubas AA, Rathmell WK. Epigenetic modifiers: activities in renal cell carcinoma. Nat Rev Urol. 2018;15:599\u2013614.","journal-title":"Nat Rev Urol"},{"key":"3505_CR6","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41585-018-0023-z","volume":"15","author":"SC Joosten","year":"2018","unstructured":"Joosten SC, Smits KM, Aarts MJ, Melotte V, Koch A, Tjan-Heijnen VC, et al. Epigenetics in renal cell cancer: mechanisms and clinical applications. Nat Rev Urol. 2018;15:430\u201351.","journal-title":"Nat Rev Urol"},{"key":"3505_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43378-w","volume":"14","author":"H Rao","year":"2023","unstructured":"Rao H, Liu C, Wang A, Ma C, Xu Y, Ye T, et al. SETD2 deficiency accelerates sphingomyelin accumulation and promotes the development of renal cancer. Nat Commun. 2023;14:7572.","journal-title":"Nat Commun"},{"key":"3505_CR8","doi-asserted-by":"publisher","first-page":"6786","DOI":"10.1093\/nar\/gkac533","volume":"50","author":"Z Li","year":"2022","unstructured":"Li Z, Zhang X, Xie S, Liu X, Fei C, Huang X, et al. H3K36me2 methyltransferase NSD2 orchestrates epigenetic reprogramming during spermatogenesis. Nucleic Acids Res. 2022;50:6786\u20136800.","journal-title":"Nucleic Acids Res"},{"key":"3505_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13173","volume":"19","author":"H Tanaka","year":"2020","unstructured":"Tanaka H, Igata T, Etoh K, Koga T, Takebayashi S, Nakao M. The NSD2\/WHSC1\/MMSET methyltransferase prevents cellular senescence-associated epigenomic remodeling. Aging Cell. 2020;19:e13173.","journal-title":"Aging Cell"},{"key":"3505_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2147\/CMAR.S222673","volume":"12","author":"X Han","year":"2020","unstructured":"Han X, Piao L, Xu X, Luo F, Liu Z, He X. NSD2 promotes renal cancer progression through stimulating Akt\/Erk Signaling. CMAR. 2020;12:375\u201383.","journal-title":"CMAR"},{"key":"3505_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nature08086","volume":"460","author":"K Nimura","year":"2009","unstructured":"Nimura K, Ura K, Shiratori H, Ikawa M, Okabe M, Schwartz RJ, et al. A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf\u2013Hirschhorn syndrome. Nature. 2009;460:287\u201391.","journal-title":"Nature"},{"key":"3505_CR12","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1038\/s41388-021-01747-z","volume":"40","author":"D Song","year":"2021","unstructured":"Song D, Lan J, Chen Y, Liu A, Wu Q, Zhao C, et al. NSD2 promotes tumor angiogenesis through methylating and activating STAT3 protein. Oncogene. 2021;40:2952\u201367.","journal-title":"Oncogene"},{"key":"3505_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrm1549","volume":"6","author":"SK Mitra","year":"2005","unstructured":"Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol. 2005;6:56\u201368.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3505_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.semcancer.2014.07.009","volume":"31","author":"I Eke","year":"2015","unstructured":"Eke I, Cordes N. Focal adhesion signaling and therapy resistance in cancer. Seminars Cancer Biol. 2015;31:65\u201375.","journal-title":"Seminars Cancer Biol"},{"key":"3505_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-169","volume":"12","author":"M Poettler","year":"2013","unstructured":"Poettler M, Unseld M, Braemswig K, Haitel A, Zielinski CC, Prager GW. CD98hc (SLC3A2) drives integrin-dependent renal cancer cell behavior. Molecular Cancer. 2013;12:169.","journal-title":"Molecular Cancer"},{"key":"3505_CR16","doi-asserted-by":"publisher","first-page":"19372","DOI":"10.1073\/pnas.1307405110","volume":"110","author":"J Seong","year":"2013","unstructured":"Seong J, Tajik A, Sun J, Guan J-L, Humphries MJ, Craig SE, et al. Distinct biophysical mechanisms of focal adhesion kinase mechanoactivation by different extracellular matrix proteins. Proc Natl Acad Sci USA. 2013;110:19372\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3505_CR17","doi-asserted-by":"publisher","first-page":"984","DOI":"10.7150\/ijms.20336","volume":"14","author":"T-W Hung","year":"2017","unstructured":"Hung T-W, Chen P-N, Wu H-C, Wu S-W, Tsai P-Y, Hsieh Y-S, et al. Kaempferol inhibits the invasion and migration of renal cancer cells through the downregulation of AKT and FAK Pathways. International J Med Sci. 2017;14:984\u201393.","journal-title":"International J Med Sci"},{"key":"3505_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309387","volume":"11","author":"W Feng","year":"2024","unstructured":"Feng W, Niu N, Lu P, Chen Z, Rao H, Zhang W, et al. Multilevel regulation of NF-\u03baB signaling by NSD2 suppresses Kras -Driven Pancreatic Tumorigenesis. Advanced Sci. 2024;11:2309387.","journal-title":"Advanced Sci"},{"key":"3505_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216470","volume":"579","author":"W Feng","year":"2023","unstructured":"Feng W, Ma C, Rao H, Zhang W, Liu C, Xu Y, et al. Setd2 deficiency promotes gastric tumorigenesis through inhibiting the SIRT1\/FOXO pathway. Cancer Lett. 2023;579:216470.","journal-title":"Cancer Lett"},{"key":"3505_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jmbbm.2013.07.008","volume":"27","author":"CD Markert","year":"2013","unstructured":"Markert CD, Guo X, Skardal A, Wang Z, Bharadwaj S, Zhang Y, et al. Characterizing the micro-scale elastic modulus of hydrogels for use in regenerative medicine. Journal Mech Behav Biomed Mater. 2013;27:115\u201327.","journal-title":"Journal Mech Behav Biomed Mater"},{"key":"3505_CR21","doi-asserted-by":"publisher","first-page":"e0181085","DOI":"10.1371\/journal.pone.0181085","volume":"12","author":"JA Beamish","year":"2017","unstructured":"Beamish JA, Chen E, Putnam AJ. Engineered extracellular matrices with controlled mechanics modulate renal proximal tubular cell epithelialization. PLoS ONE. 2017;12:e0181085.","journal-title":"PLoS ONE"},{"key":"3505_CR22","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.3390\/polym15153183","volume":"15","author":"M Guo","year":"2023","unstructured":"Guo M, Deng Y, Huang J, Huang Y, Deng J, Wu H. Fabrication and Validation of a 3D Portable PEGDA Microfluidic Chip for Visual Colorimetric Detection of Captured Breast Cancer Cells. Polymers. 2023;15:3183.","journal-title":"Polymers"},{"key":"3505_CR23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI141801","volume":"131","author":"T Doke","year":"2021","unstructured":"Doke T, Huang S, Qiu C, Liu H, Guan Y, Hu H, et al. Transcriptome-wide association analysis identifies DACH1 as a kidney disease risk gene that contributes to fibrosis. Journal Clin Investig. 2021;131:e141801.","journal-title":"Journal Clin Investig"},{"key":"3505_CR24","first-page":"11124","volume":"8","author":"M Zhao","year":"2015","unstructured":"Zhao M, Teng X, Ru G, Zhao Z, Hu Q, Han L, et al. Tubulocystic renal cell carcinoma with poorly differentiated foci is indicative of aggressive behavior: clinicopathologic study of two cases and review of the literature. Int J Clin Exp Pathol. 2015;8:11124\u201331.","journal-title":"Int J Clin Exp Pathol"},{"key":"3505_CR25","doi-asserted-by":"crossref","unstructured":"Yang XJ, Shen S, Li R, Yang Y, Tretiakova MM Tubulocystic Carcinoma of the Kidney. Am J Surg Pathol. 2008; 32:177\u2013187.","DOI":"10.1097\/PAS.0b013e318150df1d"},{"key":"3505_CR26","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00428-007-0483-7","volume":"451","author":"S Azoulay","year":"2007","unstructured":"Azoulay S, Vieillefond A, Paraf F, Pasquier D, Cussenot O, Callard P, et al. Tubulocystic carcinoma of the kidney: a new entity among renal tumors. Virchows Arch. 2007;451:905\u20139.","journal-title":"Virchows Arch"},{"key":"3505_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jmoldx.2017.09.002","volume":"20","author":"CH Lawrie","year":"2018","unstructured":"Lawrie CH, Armesto M, Fernandez-Mercado M, Arest\u00edn M, Manterola L, Goicoechea I, et al. Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms. Journal Mol Diagn. 2018;20:34\u201345.","journal-title":"Journal Mol Diagn"},{"key":"3505_CR28","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41556-023-01092-1","volume":"25","author":"B Wu","year":"2023","unstructured":"Wu B, Liu D-A, Guan L, Myint PK, Chin L, Dang H, et al. Stiff matrix induces exosome secretion to promote tumour growth. Nat Cell Biol. 2023;25:415\u201324.","journal-title":"Nat Cell Biol"},{"key":"3505_CR29","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccell.2019.01.007","volume":"35","author":"Integrin Signaling in Cancer.","year":"2019","unstructured":"Integrin Signaling in Cancer. Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance. Cancer Cell. 2019;35:347\u201367.","journal-title":"Cancer Cell"},{"key":"3505_CR30","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.1016\/j.molcel.2021.08.034","volume":"81","author":"D Sengupta","year":"2021","unstructured":"Sengupta D, Zeng L, Li Y, Hausmann S, Ghosh D, Yuan G, et al. NSD2 dimethylation at H3K36 promotes lung adenocarcinoma pathogenesis. Molecular Cell. 2021;81:4481\u20134492.e9.","journal-title":"Molecular Cell"},{"key":"3505_CR31","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3390\/cells9010192","volume":"9","author":"K Katoh","year":"2020","unstructured":"Katoh K. FAK-dependent cell motility and cell elongation. Cells. 2020;9:192.","journal-title":"Cells"},{"key":"3505_CR32","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1158\/1078-0432.CCR-15-0781","volume":"21","author":"SEM Herman","year":"2015","unstructured":"Herman SEM, Mustafa RZ, Jones J, Wong DH, Farooqui M, Wiestner A. Treatment with Ibrutinib Inhibits BTK- and VLA-4-Dependent Adhesion of Chronic Lymphocytic Leukemia Cells In Vivo. Clin Cancer Res. 2015;21:4642\u201351.","journal-title":"Clin Cancer Res"},{"key":"3505_CR33","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.ccr.2013.10.022","volume":"24","author":"E Piovan","year":"2013","unstructured":"Piovan E, Yu J, Tosello V, Herranz D, Ambesi-Impiombato A, Da Silva AC, et al. Direct Reversal of Glucocorticoid Resistance by AKT Inhibition in Acute Lymphoblastic Leukemia. Cancer Cell. 2013;24:766\u201376.","journal-title":"Cancer Cell"},{"key":"3505_CR34","doi-asserted-by":"publisher","first-page":"R383","DOI":"10.1016\/j.cub.2020.03.051","volume":"30","author":"R Sunyer","year":"2020","unstructured":"Sunyer R, Trepat X. Durotaxis. Current Biol. 2020;30:R383\u2013R387.","journal-title":"Current Biol"},{"key":"3505_CR35","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1096\/fj.201700721R","volume":"32","author":"D Lachowski","year":"2018","unstructured":"Lachowski D, Cortes E, Robinson B, Rice A, Rombouts K, Hern\u00e1ndez AEDR. FAK controls the mechanical activation of YAP, a transcriptional regulator required for durotaxis. FASEB J. 2018;32:1099\u2013107.","journal-title":"FASEB J"},{"key":"3505_CR36","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41580-021-00366-6","volume":"22","author":"S SenGupta","year":"2021","unstructured":"SenGupta S, Parent CA, Bear JE. The principles of directed cell migration. Nat Rev Mol Cell Biol. 2021;22:529\u201347.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3505_CR37","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1111\/febs.15862","volume":"289","author":"JA Espina","year":"2022","unstructured":"Espina JA, Marchant CL, Barriga EH. Durotaxis: the mechanical control of directed cell migration. FEBS J. 2022;289:2736\u201354.","journal-title":"FEBS J"},{"key":"3505_CR38","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1016\/j.cell.2022.08.008","volume":"185","author":"F-Y Lin","year":"2022","unstructured":"Lin F-Y, Li J, Xie Y, Zhu J, Nguyen TTH, Zhang Y, et al. A general chemical principle for creating closure-stabilizing integrin inhibitors. Cell. 2022;185:3533\u20133550.e27.","journal-title":"Cell"},{"key":"3505_CR39","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/ene.12097","volume":"20","author":"RA Grove","year":"2013","unstructured":"Grove RA, Shackelford S, Sopper S, Pirruccello S, Horrigan J, Havrdova E, et al. Leukocyte counts in cerebrospinal fluid and blood following firategrast treatment in subjects with relapsing forms of multiple sclerosis. Eur J Neurol. 2013;20:1032\u201342.","journal-title":"Eur J Neurol"},{"key":"3505_CR40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S1474-4422(11)70299-X","volume":"11","author":"DH Miller","year":"2012","unstructured":"Miller DH, Weber T, Grove R, Wardell C, Horrigan J, Graff O, et al. Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2012;11:131\u20139.","journal-title":"Lancet Neurol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03505-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03505-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03505-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T22:07:07Z","timestamp":1757282827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03505-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":40,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2025,9,29]]}},"alternative-id":["3505"],"URL":"https:\/\/doi.org\/10.1038\/s41388-025-03505-x","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}